Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Concetta Castilletti

Showing results (171-180 of 184) with videos related to

Pageof 19
Sort By:
Cells|October 23, 2021
Highly Specific Memory B Cells Generation after the 2nd Dose of BNT162b2 Vaccine Compensate for the Decline of Serum Antibodies and Absence of Mucosal IgAEva Piano Mortari, Cristina Russo, Maria Rosaria Vinci, et al.
NPJ Vaccines|September 24, 2022
Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial resultsChiara Agrati, Concetta Castilletti, Simone Battella, et al.
Science Translational Medicine|October 26, 2021
GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adultsSimone Lanini, Stefania Capone, Andrea Antinori, et al.
The Journal of Infectious Diseases|July 16, 2025
Multicenter Cross-sectional Study on the Epidemiology of Human Metapneumovirus in Italy, 2022-2024, With a Focus on Adults Over 50 Years of AgeAlessandro Mancon, Laura Pellegrinelli, Greta Romano, et al.
Cell|March 5, 2021
Extremely potent human monoclonal antibodies from COVID-19 convalescent patientsEmanuele Andreano, Emanuele Nicastri, Ida Paciello, et al.
Cell Reports. Medicine|March 10, 2026
Human liver-derived organoids recapitulate Oropouche virus infection and manifestation, enabling antiviral drug discoveryJiajing Li, Xin Wang, Yibo Ding, et al.
Viruses|September 16, 2020
Chikungunya Outbreak in the Republic of the Congo, 2019-Epidemiological, Virological and Entomological Findings of a South-North Multidisciplinary Taskforce InvestigationFrancesco Vairo, Martin Parfait Aimè Coussoud-Mavoungou, Francine Ntoumi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 21, 2021
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal modelsAntonella Conforti, Emanuele Marra, Fabio Palombo, et al.
The European Respiratory Journal|June 27, 2020
Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC)Catherine Wei Min Ong, Giovanni Battista Migliori, Mario Raviglione, et al.
The Journal of Infectious Diseases|September 18, 2016
Analysis of Diagnostic Findings From the European Mobile Laboratory in Guéckédou, Guinea, March 2014 Through March 2015Romy Kerber, Ralf Krumkamp, Boubacar Diallo, et al.
Pageof 19

Showing results (171-180 of 184) with videos related to

Sort By:
Pageof 19
Cells|October 23, 2021
Highly Specific Memory B Cells Generation after the 2nd Dose of BNT162b2 Vaccine Compensate for the Decline of Serum Antibodies and Absence of Mucosal IgAEva Piano Mortari, Cristina Russo, Maria Rosaria Vinci, et al.
NPJ Vaccines|September 24, 2022
Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial resultsChiara Agrati, Concetta Castilletti, Simone Battella, et al.
Science Translational Medicine|October 26, 2021
GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adultsSimone Lanini, Stefania Capone, Andrea Antinori, et al.
The Journal of Infectious Diseases|July 16, 2025
Multicenter Cross-sectional Study on the Epidemiology of Human Metapneumovirus in Italy, 2022-2024, With a Focus on Adults Over 50 Years of AgeAlessandro Mancon, Laura Pellegrinelli, Greta Romano, et al.
Cell|March 5, 2021
Extremely potent human monoclonal antibodies from COVID-19 convalescent patientsEmanuele Andreano, Emanuele Nicastri, Ida Paciello, et al.
Cell Reports. Medicine|March 10, 2026
Human liver-derived organoids recapitulate Oropouche virus infection and manifestation, enabling antiviral drug discoveryJiajing Li, Xin Wang, Yibo Ding, et al.
Viruses|September 16, 2020
Chikungunya Outbreak in the Republic of the Congo, 2019-Epidemiological, Virological and Entomological Findings of a South-North Multidisciplinary Taskforce InvestigationFrancesco Vairo, Martin Parfait Aimè Coussoud-Mavoungou, Francine Ntoumi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 21, 2021
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal modelsAntonella Conforti, Emanuele Marra, Fabio Palombo, et al.
The European Respiratory Journal|June 27, 2020
Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC)Catherine Wei Min Ong, Giovanni Battista Migliori, Mario Raviglione, et al.
The Journal of Infectious Diseases|September 18, 2016
Analysis of Diagnostic Findings From the European Mobile Laboratory in Guéckédou, Guinea, March 2014 Through March 2015Romy Kerber, Ralf Krumkamp, Boubacar Diallo, et al.
Pageof 19